Miracor Medical Systems is commercializing a unique and potentially disruptive technology, PICSO®, for acute coronary syndrome (“ACS”, or “heart attack”), heart failure and cardiac surgery patients.

Miracor is an Austrian medical device company dedicated to develop and commercialize the PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) technology. The PICSO® technology intermittently occludes the outflow of venous blood from the heart muscle. This occlusion shortly increases the pressure in the myocardium which is believed to have a positive effect after a heart attack. Clinical data is already available documenting the positive impact of PICSO® in patients undergoing revascularization procedures after thrombolytic therapy. Miracor aims to develop a completely new platform for the PICSO® technology called the Miracor PICSO® Impulse System consisting of a driving console and associated catheters.The company will conduct new clinical trials to document the safety and effectiveness of the PICSO® Impulse System in patients undergoing coronary revascularization with percutaneous coronary intervention (PCI).

Gumpendorferstraße 139/1.05
1060 Wien

+43 1 23665760



Follow @Miracor_Medical on twitter.

  • Start-Up Search


  • Über INiTS

    INiTS hat sich als Business-Inkubator das Ziel gesetzt, die Erfolgswahrscheinlichkeit von Startups im Raum Wien zu erhöhen. Dabei unterstützt INiTS JungunternehmerInnen dabei, ihre Ideen in ein wachstumsstarkes und erfolgreiches Unternehmen umzusetzen. more

© INiTS Universitäres Gründerservice Wien GmbH, eine Gesellschaft von:

  • Logo TU Wien
  • Logo Uni Wien

Gefördert von:

  • Logo Wirtschaftsagentur
  • Logo FFG